• Reset

Treatment of advanced breast cancer with adoptive therapy of CD3+/PD1+ tumor infiltrating lymphocytes. Leer mas
A window-of-opportunity study of U3-1402, a HER3-targeting antibody-drug conjugate in operable breast cancer according to Leer mas
Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse (TREAT ctDNA) Leer mas
A Phase II Trial Testing Durvalumab Combined With Endocrine Therapy in Patients With ER+/Her2- Breast Leer mas
A phase 2 trial of neoadjuVAnt muLti-agENT chemotherapy or patritumab deruxtecan (HER3-DXd; U3-1402 with or Leer mas
Phase 0 multicenter, window of opportunity, three-arm, randomized clinical trial of oral metronomic vinorelbine and Leer mas
An open-label study of the effect of first-line Herceptin® alone or in combination with a Leer mas